Monkeypox vaccine ‘IMVANEX’ approved in Europe

Daily Current Affairs / Monkeypox vaccine ‘IMVANEX’ approved in Europe

Change Language English Hindi

Category : International Published on: July 27 2022

Share on facebook

The European Commission has approved a smallpox vaccine for use against monkeypox after the World Health Organization declared monkeypox a global health emergency.
Imvanex has been approved in the EU since 2013 for the prevention of smallpox.
It was also considered a potential vaccine for monkeypox because of the similarity between the monkeypox virus and the smallpox virus.
Monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980.
The first symptoms of monkeypox are fever, headaches, muscle pain and back pain during the course of five days.

Monkeypox vaccine ‘IMVANEX’ approved in Europe